Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

CytomX Therapeutics (CTMX) Interest Expenses (2016 - 2017)

Historic Interest Expenses for CytomX Therapeutics (CTMX) over the last 4 years, with Q1 2017 value amounting to $206000.0.

  • CytomX Therapeutics' Interest Expenses fell 4164.31% to $206000.0 in Q1 2017 from the same period last year, while for Dec 2017 it was $206000.0, marking a year-over-year decrease of 8780.34%. This contributed to the annual value of $1.7 million for FY2016, which is 248.27% down from last year.
  • As of Q1 2017, CytomX Therapeutics' Interest Expenses stood at $206000.0, which was down 4164.31% from $389000.0 recorded in Q4 2016.
  • CytomX Therapeutics' Interest Expenses' 5-year high stood at $718000.0 during Q3 2015, with a 5-year trough of $109000.0 in Q4 2014.
  • Over the past 4 years, CytomX Therapeutics' median Interest Expenses value was $376000.0 (recorded in 2015), while the average stood at $350272.7.
  • As far as peak fluctuations go, CytomX Therapeutics' Interest Expenses skyrocketed by 51367.52% in 2015, and later crashed by 4164.31% in 2017.
  • CytomX Therapeutics' Interest Expenses (Quarter) stood at $109000.0 in 2014, then skyrocketed by 244.95% to $376000.0 in 2015, then increased by 3.46% to $389000.0 in 2016, then plummeted by 47.04% to $206000.0 in 2017.
  • Its Interest Expenses was $206000.0 in Q1 2017, compared to $389000.0 in Q4 2016 and $482000.0 in Q3 2016.